Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021

SELL
$101.99 - $166.36 $7.1 Million - $11.6 Million
-69,592 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$141.6 - $179.06 $795,367 - $1.01 Million
-5,617 Reduced 7.47%
69,592 $11.5 Million
Q1 2021

May 13, 2021

BUY
$132.81 - $182.18 $119,661 - $164,144
901 Added 1.21%
75,209 $10.5 Million
Q4 2020

Feb 11, 2021

BUY
$138.17 - $184.34 $192,885 - $257,338
1,396 Added 1.91%
74,308 $12.9 Million
Q3 2020

Nov 09, 2020

BUY
$114.09 - $145.51 $97,204 - $123,974
852 Added 1.18%
72,912 $10.2 Million
Q2 2020

Aug 13, 2020

BUY
$89.45 - $129.85 $44,277 - $64,275
495 Added 0.69%
72,060 $8.61 Million
Q1 2020

May 06, 2020

SELL
$70.23 - $144.31 $105,274 - $216,320
-1,499 Reduced 2.05%
71,565 $7.16 Million
Q4 2019

Feb 14, 2020

BUY
$76.41 - $117.54 $5.58 Million - $8.59 Million
73,064 New
73,064 $8.59 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $140M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Fuller & Thaler Asset Management, Inc. Portfolio

Follow Fuller & Thaler Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fuller & Thaler Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Fuller & Thaler Asset Management, Inc. with notifications on news.